{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:19:13Z","timestamp":1792448353843,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T00:00:00Z","timestamp":1640908800000},"content-version":"vor","delay-in-days":305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.brainresbull.2020.12.011","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T00:13:15Z","timestamp":1609373595000},"page":"63-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Ketamine reversed short-term memory impairment and depressive-like behavior in animal model of Parkinson's disease"],"prefix":"10.1016","volume":"168","author":[{"given":"D\u00e9bora Dalla","family":"Vecchia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Kae Sales","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eti\u00e9li","family":"Wendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palloma de Almeida Soares","family":"Hocayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida Barbato Fraz\u00e3o","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinaldo Naoto","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmar","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Andreatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2020.12.011_bib0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.biopsych.2012.05.003","article-title":"Ketamine for depression: where do we go from here?","volume":"72","author":"aan het Rot","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","article-title":"Depression in Parkinson disease - epidemiology, mechanisms and management","volume":"8","author":"Aarsland","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0015","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s11064-010-0222-3","article-title":"Intranigral LPS administration produces dopamine, glutathione but not behavioral impairment in comparison to MPTP and 6-OHDA neurotoxin models of Parkinson\u2019s disease","volume":"35","author":"Ariza","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2015.11.047","article-title":"Long-term effect of sub-anesthetic ketamine in reducing L-DOPA-induced dyskinesias in a preclinical model","volume":"612","author":"Bartlett","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113413","article-title":"Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia","volume":"333","author":"Bartlett","year":"2020","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.brainresbull.2020.12.011_bib0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nlm.2004.06.006","article-title":"Is the unilateral lesion of the left substantia nigra pars compacta sufficient to induce working memory impairment in rats?","volume":"82","author":"Bellissimo","year":"2004","journal-title":"Neurobiol. Learn. Mem."},{"issue":"1","key":"10.1016\/j.brainresbull.2020.12.011_bib0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mds.25108","article-title":"Animal models of Parkinson\u2019s disease: limits and relevance to neuroprotection studies","volume":"28","author":"Bezard","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0301-0082(99)00067-2","article-title":"Functional changes of the basal ganglia circuitry in Parkinson\u2019s disease","volume":"62","author":"Blandini","year":"2000","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.brainresbull.2020.12.011_bib0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1460-9568.2006.05285.x","article-title":"Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioral alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model","volume":"25","author":"Blandini","year":"2007","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.brainresbull.2020.12.011_bib0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0006-8993(90)91613-L","article-title":"Social recognition does not involve vasopressinergic neurotransmission in female rats","volume":"535","author":"Bluth\u00e9","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2011.10.057","article-title":"Neurotoxin-based models of Parkinson\u2019s disease","volume":"211","author":"Bov\u00e9","year":"2012","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.brainresbull.2020.12.011_bib0060","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.biopsych.2015.04.022","article-title":"Ketamine as a prophylactic against stress-induced depressive-like behavior","volume":"79","author":"Brachman","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fphar.2013.00161","article-title":"Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants","volume":"4","author":"Browne","year":"2013","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.brainresbull.2020.12.011_bib0070","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/acn3.246","article-title":"Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease","volume":"2","author":"Buddhala","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"3","key":"10.1016\/j.brainresbull.2020.12.011_bib0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF01258633","article-title":"The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice","volume":"75","author":"Carlsson","year":"1989","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.brainresbull.2020.12.011_bib0080","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbr.2012.01.016","article-title":"Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson\u2019s disease","volume":"229","author":"Castro","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.brainresbull.2020.12.011_bib0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.brainresbull.2020.12.011_bib0090","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1017\/S1461145714000236","article-title":"SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats","volume":"17","author":"Chen","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.parkreldis.2018.02.048","article-title":"Effect of striatal dopamine depletion on cognition in de novo Parkinson\u2019s disease","volume":"51","author":"Chung","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0100","series-title":"Animal Models for the Study of Human Disease","first-page":"1109","article-title":"Animal models for the study of human neurodegenerative diseases","author":"Colpo","year":"2017"},{"issue":"6","key":"10.1016\/j.brainresbull.2020.12.011_bib0105","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.euroneuro.2006.01.003","article-title":"Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test","volume":"16","author":"Consoni","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0166-4328(01)00211-X","article-title":"Memory disruption in rats with nigral lesion induced by MPTP: a model for early Parkinson\u2019s disease amnesia","volume":"124","author":"Da Cunha","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1074-7427(03)00008-X","article-title":"Evidence for the substantia nigra pars compacta as an essential component of a memory system independent of the hippocampal memory system","volume":"79","author":"Da Cunha","year":"2003","journal-title":"Neurobiol Learning Memory"},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbr.2008.10.001","article-title":"Learning processing in the basal ganglia: a mosaic of broken mirrors","volume":"199","author":"Da Cunha","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00518192","article-title":"Modulation of social memory in male rats by neurohypophyseal peptides","volume":"91","author":"Dantzer","year":"1987","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0135","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bbr.2017.06.016","article-title":"Chronic pramipexole treatment induces compulsive behavior in rats with 6-OHDA lesions of the substantia nigra and ventral tegmental area","volume":"332","author":"Dardou","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"7","key":"10.1016\/j.brainresbull.2020.12.011_bib0140","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/jnnp-2011-301817","article-title":"Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson\u2019s disease-related dementia","volume":"84","author":"Del Tredici","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnsys.2011.00031","article-title":"Noradrenaline and Parkinson\u2019s disease","volume":"5","author":"Delaville","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0150","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.brainresbull.2020.12.011_bib0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","article-title":"Modeling Parkinson\u2019s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway","volume":"175","author":"Deumens","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0160","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.brainresbull.2019.06.014","article-title":"Differential impairment of short working and spatial memories in a rat model of progressive Parkinson\u2019s disease onset: a focus on the prodromal stage","volume":"150","author":"Draoui","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0165","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/mp.2013.3","article-title":"Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson\u2019s disease","volume":"19","author":"Drui","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"14","key":"10.1016\/j.brainresbull.2020.12.011_bib0170","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1007\/s00213-016-4327-5","article-title":"Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression","volume":"233","author":"du Jardin","year":"2016","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pnpbp.2016.05.007","article-title":"Potential involvement of serotonergic signaling in ketamine\u2019s antidepressant actions: A critical review","volume":"71","author":"du Jardin","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.31887\/DCNS.2014.16.1\/rduman","article-title":"Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections","volume":"16","author":"Duman","year":"2014","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.08.044","article-title":"Signaling pathways underlying the rapid antidepressant actions of ketamine","volume":"62","author":"Duman","year":"2012","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.brainresbull.2020.12.011_bib0190","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.neubiorev.2010.06.007","article-title":"Potential mechanisms underlying anxiety and depression in Parkinson\u2019s disease: consequences of l-DOPA treatment","volume":"35","author":"Eskow Jaunarajs","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0195","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.neubiorev.2018.10.004","article-title":"The hidden side of Parkinson\u2019s disease: studying pain, anxiety and depression in animal models","volume":"96","author":"Faivre","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104818","article-title":"Ablation of the tail of the ventral tegmental area compensates symptoms in an experimental model of Parkinson\u2019s disease","volume":"139","author":"Faivre","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.brainresbull.2020.12.011_bib0205","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.apjtm.2017.09.014","article-title":"Neuron-protective effect of subanesthestic-dosage ketamine on mice of Parkinson\u2019s disease","volume":"10","author":"Fan","year":"2017","journal-title":"Asian Pac. J. Trop. Med."},{"issue":"1","key":"10.1016\/j.brainresbull.2020.12.011_bib0210","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneumeth.2005.04.005","article-title":"Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson\u2019s disease: histological, neurochemical, motor and memory alterations","volume":"148","author":"Ferro","year":"2005","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0100-879X2007000100012","article-title":"Neuroprotective effect of ketamine\/xylazine in two rat models of Parkinson\u2019s disease","volume":"40","author":"Ferro","year":"2007","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"1","key":"10.1016\/j.brainresbull.2020.12.011_bib0220","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00213-019-05346-5","article-title":"MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling","volume":"237","author":"Fujita","year":"2020","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.brainresbull.2020.12.011_bib0225","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","article-title":"Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus","volume":"32","author":"Garcia","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0361-9230(01)00501-9","article-title":"Caffeine reverses the memory disruption induced by intra-nigral MPTP-injection in rats","volume":"55","author":"Gevaerd","year":"2001","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.brainresbull.2020.12.011_bib0235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-013-3024-x","article-title":"Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism","volume":"228","author":"Gigliucci","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.brainresbull.2020.12.011_bib0240","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2009.08.007","article-title":"A timeline for Parkinson\u2019s disease","volume":"16","author":"Hawkes","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.brainresbull.2020.12.011_bib0245","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbr.2011.01.028","article-title":"Effects of D-cycloserine on MPTP-induced behavioral and neurological changes: potential for treatment of Parkinson\u2019s disease dementia","volume":"219","author":"Ho","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.brainresbull.2020.12.011_bib0250","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbr.2011.12.035","article-title":"Effects of MK-801 on recognition and neurodegeneration in an MPTP-induced Parkinson\u2019s rat model","volume":"229","author":"Hsieh","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0255","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.brainresbull.2017.05.015","article-title":"Ceftriaxone reverses deficits of behavior and neurogenesis in an MPTP-induced rat model of Parkinson\u2019s disease dementia","volume":"132","author":"Hsieh","year":"2017","journal-title":"Brain Res. Bull."},{"issue":"17","key":"10.1016\/j.brainresbull.2020.12.011_bib0260","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s00213-015-3957-3","article-title":"Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway","volume":"232","author":"Jett","year":"2015","journal-title":"Psychopharmacology (Berl.)"},{"issue":"9996","key":"10.1016\/j.brainresbull.2020.12.011_bib0265","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0270","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.bbr.2016.09.056","article-title":"Lack of effect of chronic ketamine administration on depression-like behavior and frontal cortex autophagy in female and male ICR mice","volume":"317","author":"Kara","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0275","first-page":"1","article-title":"Locomotor activity and exploration","volume":"Vol. 2","author":"Kelley","year":"1993"},{"issue":"2","key":"10.1016\/j.brainresbull.2020.12.011_bib0280","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00213-004-1799-5","article-title":"NMDA receptor antagonists ameliorate the stepping deficits produced by unilateral medial forebrain bundle injections of 6-OHDA in rats","volume":"175","author":"Kelsey","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.brainresbull.2020.12.011_bib0285","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu033","article-title":"BDNF release is required for the behavioral actions of ketamine","volume":"18","author":"Lepack","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.brainresbull.2020.12.011_bib0290","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1017\/neu.2014.39","article-title":"Nitric oxide involvement in the antidepressant-like effect of ketamine in the Flinders sensitive line rat model of depression","volume":"27","author":"Liebenberg","year":"2014","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0295","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2006.05.016","article-title":"Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats","volume":"1101","author":"Lima","year":"2006","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.brainresbull.2020.12.011_bib0300","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1460-9568.2012.08162.x","article-title":"Cognitive dysfunction and depression in Parkinson\u2019s disease: what can be learned from rodent models?","volume":"35","author":"Lindgren","year":"2012","journal-title":"Eur. J. Neurosci."},{"issue":"7","key":"10.1016\/j.brainresbull.2020.12.011_bib0305","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1021\/acschemneuro.9b00288","article-title":"Role of serotonin and noradrenaline in the rapid antidepressant action of ketamine","volume":"10","author":"L\u00f3pez-Gil","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"10.1016\/j.brainresbull.2020.12.011_bib0310","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/WCO.0000000000000218","article-title":"Apathy and noradrenaline: silent partners to mild cognitive impairment in Parkinson\u2019s disease?","volume":"28","author":"Loued-Khenissi","year":"2015","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0315","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbr.2011.03.022","article-title":"Neonatal exposure to constant light prevents anhedonia-like behavior induced by constant light exposure in adulthood","volume":"222","author":"Martynhak","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0320","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0361-9230(02)00754-2","article-title":"Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTP-induced mesencephalic dopaminergic lesions","volume":"58","author":"Miyoshi","year":"2002","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.brainresbull.2020.12.011_bib0325","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neures.2004.11.008","article-title":"Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL\/6 mice","volume":"51","author":"Mori","year":"2005","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0330","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1590\/0004-282X20150029","article-title":"Non-motor signs in Parkinson\u2019s disease: a review","volume":"73","author":"Munhoz","year":"2015","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0335","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jad.2013.11.014","article-title":"A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action","volume":"156","author":"Naughton","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0340","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.lfs.2016.05.022","article-title":"A promising therapeutic potential of cerebrolysin in 6-OHDA rat model of Parkinson\u2019s disease","volume":"155","author":"Noor","year":"2016","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.brainresbull.2020.12.011_bib0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FBP.0000000000000259","article-title":"Antidepressant, anxiolytic and procognitive effects of subacute and chronic ketamine in the chronic mild stress model of depression","volume":"28","author":"Papp","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0350","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2005"},{"issue":"12","key":"10.1016\/j.brainresbull.2020.12.011_bib0355","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.biopsych.2013.01.021","article-title":"Glutamate-based antidepressants: preclinical psychopharmacology","volume":"73","author":"Pilc","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0360","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbr.2003.11.009","article-title":"Facilitation of short-term social memory by ethanol in rats is mediated by dopaminergic receptors","volume":"153","author":"Prediger","year":"2004","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.brainresbull.2020.12.011_bib0365","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12640-009-9087-0","article-title":"Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine in C57BL\/6 mice models early preclinical phase of Parkinson\u2019s disease","volume":"17","author":"Prediger","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0370","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson\u2019s disease are predominantly associated with serotonin and dopamine","volume":"6","author":"Santiago","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0375","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuroscience.2015.05.030","article-title":"The nonsteroidal antiinflammatory drug piroxicam reverses the onset of depressive-like behavior in 6-OHDA animal model of Parkinson\u2019s disease","volume":"300","author":"Santiago","year":"2015","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.brainresbull.2020.12.011_bib0380","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3233\/JPD-2012-12076","article-title":"Studies of depression-related states in animal models of Parkinsonism","volume":"2","author":"Schintu","year":"2012","journal-title":"J. Parkinsons Dis."},{"issue":"3","key":"10.1016\/j.brainresbull.2020.12.011_bib0385","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jnnp.69.3.308","article-title":"What contributes to quality of life in patients with Parkinson\u2019s disease?","volume":"69","author":"Schrag","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0390","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0166-4328(85)90036-1","article-title":"Deficits in inhibitory avoidance after neurotoxic lesions of the ventral striatum are neurochemically and behaviorally selective","volume":"18","author":"Schwarting","year":"1985","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0395","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0301-0082(96)00015-9","article-title":"Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae","volume":"49","author":"Schwarting","year":"1996","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.brainresbull.2020.12.011_bib0400","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s12640-015-9519-y","article-title":"Neurotoxin mechanisms and processes relevant to Parkinson\u2019s disease: an update","volume":"27","author":"Segura-Aguilar","year":"2015","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.brainresbull.2020.12.011_bib0405","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000444278","article-title":"Case reports showing a long-term effect of subanesthetic ketamine infusion in reducing L-dopa-induced dyskinesias","volume":"8","author":"Sherman","year":"2016","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0410","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nprot.2012.044","article-title":"Using the rat forced swim test to assess antidepressant-like activity in rodents","volume":"7","author":"Slattery","year":"2012","journal-title":"Nat. Protoc."},{"issue":"10","key":"10.1016\/j.brainresbull.2020.12.011_bib0415","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1101\/lm.032029.113","article-title":"Understanding cognitive deficits in Parkinson\u2019s disease: lessons from preclinical animal models","volume":"20","author":"Solari","year":"2013","journal-title":"Learn. Mem."},{"issue":"4","key":"10.1016\/j.brainresbull.2020.12.011_bib0420","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mdc3.12507","article-title":"Management of depression in Parkinson\u2019s Disease: a systematic review","volume":"4","author":"Starkstein","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0425","doi-asserted-by":"crossref","first-page":"e741","DOI":"10.1038\/tp.2016.21","article-title":"Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model","volume":"6","author":"Sun","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.brainresbull.2020.12.011_bib0430","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1474-4422(12)70152-7","article-title":"Cognitive impairment in patients with Parkinson\u2019s disease: diagnosis, biomarkers, and treatment","volume":"11","author":"Svenningsson","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0435","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","article-title":"Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson\u2019s Disease","volume":"156","author":"Tadaiesky","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0440","article-title":"Effects of SR141716A on cognitive and depression-related behavior in an animal model of premotor Parkinson\u2019s disease","volume":"2010","author":"Tadaiesky","year":"2010","journal-title":"Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.brainresbull.2020.12.011_bib0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-015-9577-1","article-title":"Duality of antidepressants and neuroprotectants","volume":"30","author":"Tizabi","year":"2016","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0450","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1523\/JNEUROSCI.14-11-06317.1994","article-title":"Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson\u2019s disease, Alzheimer\u2019s disease, and mixed Parkinson\u2019s disease\/Alzheimer\u2019s disease patients: an autoradiographic study","volume":"14","author":"Ulas","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0455","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S1984-82502015000100012","article-title":"Effects of Hypericum perforatum on turning behavior in an animal model of Parkinson\u2019s disease","volume":"51","author":"Vecchia","year":"2015","journal-title":"Braz J Pharm Sci"},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2017.12.041","article-title":"Effects of ketamine on vocal impairment, gait changes, and anhedonia induced by bilateral 6-OHDA infusion into the substantia nigra pars compacta in rats: therapeutic implications for Parkinson\u2019s disease","volume":"342","author":"Vecchia","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0465","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuint.2016.11.009","article-title":"Targeting the norepinephrinergic system in Parkinson\u2019s disease and related disorders: the locus coeruleus story","volume":"102","author":"Vermeiren","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.111981","article-title":"Anxiety-like behavior induced by 6-OHDA animal model of Parkinson\u2019s disease may be related to a dysregulation of neurotransmitter systems in brain areas related to anxiety","volume":"371","author":"Vieira","year":"2019","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.brainresbull.2020.12.011_bib0475","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbr.2009.11.006","article-title":"Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats","volume":"208","author":"Wang","year":"2010","journal-title":"Behav. Brain Res."},{"issue":"12","key":"10.1016\/j.brainresbull.2020.12.011_bib0480","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","article-title":"Attenuation of antidepressant effects of ketamine by opioid receptor antagonism","volume":"175","author":"Williams","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.brainresbull.2020.12.011_bib0485","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s002130050456","article-title":"Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation","volume":"134","author":"Willner","year":"1997","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.brainresbull.2020.12.011_bib0490","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbr.2007.07.002","article-title":"Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats","volume":"84","author":"Winter","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"7604","key":"10.1016\/j.brainresbull.2020.12.011_bib0495","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2020.12.011_bib0500","first-page":"35","article-title":"Modulators of the glutamatergic system: implications for the development of improved therapeutics in mood disorders","volume":"36","author":"Zarate","year":"2002","journal-title":"Psycopharmacol Bull"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923020307280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923020307280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:42:16Z","timestamp":1759783336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923020307280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":100,"alternative-id":["S0361923020307280"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2020.12.011","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketamine reversed short-term memory impairment and depressive-like behavior in animal model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2020.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}